wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37205521-038DDBB5-E58B-4F8D-9E94-4258825C8913
Q37205521-038DDBB5-E58B-4F8D-9E94-4258825C8913
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37205521-038DDBB5-E58B-4F8D-9E94-4258825C8913
Are we HER-ting for innovation in neoadjuvant breast cancer trial design?
P2860
Q37205521-038DDBB5-E58B-4F8D-9E94-4258825C8913
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37205521-038DDBB5-E58B-4F8D-9E94-4258825C8913
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
51bc8a9377c2ccaf0849c74be51470893de67617
P2860
MRI phenotype is associated with response to doxorubicin and cyclophosphamide neoadjuvant chemotherapy in stage III breast cancer.